Published in
Elsevier, JTO Clinical and Research Reports, 5(3), p. 100322, 2022
DOI: 10.1016/j.jtocrr.2022.100322
Links
Tools
Overall Survival Benefits of First-Line Treatments for Asian Patients With Advanced EGFR-Mutated NSCLC Harboring L858R Mutation: A Systematic Review and Network Meta-Analysis
This paper is made freely available by the publisher.
Full text: Download
Postprint:
archiving forbidden
Data provided by 